Microba Life Sciences Ltd (MAP) — Financial Flexibility Index
Microba Life Sciences Ltd (MAP) has a Financial Flexibility Index of -0.45x as of December 2025. Free cash flow of AU$-5.51 Million (operating CF AU$-5.70 Million minus capex AU$189.71K) represents 0% of total liabilities (AU$12.27 Million). Check Microba Life Sciences Ltd tangible book value ratio to evaluate the tangible quality of the company's equity base.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Microba Life Sciences Ltd Financial Flexibility Index (2018–2024)
Historical Financial Flexibility Index trend for Microba Life Sciences Ltd across 7 annual periods. For the full cash flow conversion analysis, see Microba Life Sciences Ltd cash conversion from operations.
Annual Financial Flexibility Index for Microba Life Sciences Ltd (2018–2024)
Year-by-year free cash flow to debt coverage for Microba Life Sciences Ltd. Explore cash flow to debt ratio of Microba Life Sciences Ltd to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (AUD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | -0.61x | AU$-9.11 Million | AU$-12.01 Million | AU$14.94 Million | ▲ +8.3% |
| 2023 | -0.66x | AU$-11.19 Million | AU$-15.57 Million | AU$16.82 Million | ▲ +41.5% |
| 2022 | -1.14x | AU$-9.36 Million | AU$-12.39 Million | AU$8.23 Million | ▲ +21.2% |
| 2021 | -1.44x | AU$-8.58 Million | AU$-10.45 Million | AU$5.94 Million | ▲ +21.3% |
| 2020 | -1.83x | AU$-6.51 Million | AU$-7.18 Million | AU$3.55 Million | ▼ -64.1% |
| 2019 | -1.12x | AU$-3.47 Million | AU$-4.32 Million | AU$3.10 Million | ▲ +42.5% |
| 2018 | -1.94x | AU$-2.78 Million | AU$-3.62 Million | AU$1.43 Million | — |